StonvexLoading…
StonvexStonvexStonvexCore line items from SITM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $326.66M | $202.70M | $143.99M | $283.61M |
Operating Income | $-66.98M | $-115.24M | $-107.20M | $16.14M |
Net Income | $-42.90M | $-93.60M | $-80.53M | $23.25M |
EPS (Diluted) | $-1.72 | $-4.05 | $-3.63 | $1.03 |
Total Assets | $1.29B | $884.96M | $951.68M | $750.62M |
Total Liabilities | $138.52M | $185.24M | $243.63M | $42.14M |
Cash & Equivalents | $16.76M | $6.11M | $9.47M | $34.60M |
Free Cash Flow OCF − CapEx | $35.13M | $-13.03M | $-889.00K | $7.96M |
Shares Outstanding | 26.30M | 23.60M | 22.69M | 21.70M |